Page last updated: 2024-08-16

thalidomide and thromboplastin

thalidomide has been researched along with thromboplastin in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (16.67)	29.6817
2010's	5 (83.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arkel, YS; Ku, DH; Thurston, AL	1
Auwerda, JJ; Bertina, RM; de Maat, MP; Leebeek, FW; Osanto, S; Sonneveld, P; Yuana, Y	1
Asmis, LM; Kaech, A; Leikauf, MS; Madon, J; Ruf, W; Valsami, S	1
Chung, J; Hoshi, A; Isozumi, Y; Koyama, T; Matsumoto, A	1
Arai, R; Fujimoto, K; Isozumi, Y; Koyama, T	1
Gao, Y; Liu, S; Ma, G; Su, Y; Teng, Y; Wang, Y	1

Trials

1 trial(s) available for thalidomide and thromboplastin

Article	Year
Microparticle-associated tissue factor activity and venous thrombosis in multiple myeloma. Thrombosis and haemostasis, 2011, Volume: 105, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Case-Control Studies; Cell-Derived Microparticles; Dexamethasone; Doxorubicin; Female; Humans; Male; Middle Aged; Multiple Myeloma; Pyrazines; Thalidomide; Thromboplastin; Venous Thrombosis; Vincristine	2011

Article

Year

Microparticle-associated tissue factor activity and venous thrombosis in multiple myeloma.

Thrombosis and haemostasis, 2011, Volume: 105, Issue:1

Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Case-Control Studies; Cell-Derived Microparticles; Dexamethasone; Doxorubicin; Female; Humans; Male; Middle Aged; Multiple Myeloma; Pyrazines; Thalidomide; Thromboplastin; Venous Thrombosis; Vincristine

2011

Other Studies

5 other study(ies) available for thalidomide and thromboplastin

Article	Year
The effect of thalidomide on tissue factor activity in Mono Mac 6 cells and the relationship to tumor necrosis factor (TNF)-alpha-stimulated cells. Journal of thrombosis and haemostasis : JTH, 2003, Volume: 1, Issue:12 Topics: Cell Line; Humans; Monocytes; Thalidomide; Thromboplastin; Tumor Necrosis Factor-alpha	2003
Immunomodulatory drugs increase endothelial tissue factor expression in vitro. Thrombosis research, 2011, Volume: 127, Issue:3 Topics: Cell Line; Endothelial Cells; Humans; Immunologic Factors; Lenalidomide; RNA, Messenger; Thalidomide; Thromboplastin; Umbilical Veins; Up-Regulation	2011
Activation of coagulation by a thalidomide-based regimen. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2011, Volume: 22, Issue:6 Topics: Annexin A5; Anticoagulants; Antineoplastic Agents; Blood Coagulation; Blood Coagulation Factors; Cell Line; Dexamethasone; Doxorubicin; Drug Combinations; Drug Interactions; Endothelial Cells; Endothelium, Vascular; Flow Cytometry; Humans; Monocytes; Multiple Myeloma; Phosphatidylserines; Thalidomide; Thromboplastin; Venous Thrombosis	2011
Activation of coagulation by lenalidomide-based regimens for the treatment of multiple myeloma. PloS one, 2013, Volume: 8, Issue:5 Topics: Blood Coagulation; Boronic Acids; Bortezomib; Cell Line; Cell Line, Tumor; Dexamethasone; Humans; Lenalidomide; Multiple Myeloma; Phosphatidylserines; Pyrazines; Thalidomide; Thromboplastin	2013
Thalidomide and multiple myeloma serum synergistically induce a hemostatic imbalance in endothelial cells in vitro. Thrombosis research, 2015, Volume: 135, Issue:6 Topics: Adult; Angiogenesis Inhibitors; Antigens, CD; Coagulants; Dexamethasone; Endothelial Cells; Endothelial Protein C Receptor; Female; Hemostasis; Human Umbilical Vein Endothelial Cells; Humans; Interleukin-6; Male; Middle Aged; Multiple Myeloma; Phosphatidylserines; Receptors, Cell Surface; Thalidomide; Thrombomodulin; Thromboplastin; Tumor Necrosis Factor-alpha; Venous Thrombosis	2015